CDKN1A and melanoma: Further, treatment of GSPs also reduced the levels of pRbThr356, E2F1 and E2F2 proteins in melanoma cells which are the downstream targets of p21/WAF1/Cip1, and this effect of GSPs was dose-dependent (Fig. 5C).